It was announced today that Lumeon has been selected to the Cedars-Sinai Accelerator Powered by Techstars. We are one of just ten companies who beat off the rest of the competition to secure a sought-after place in the 2017 cohort. The accelerator offers a unique opportunity to work closely with business and clinical leaders at Cedars-Sinai, the largest non-profit academic medical center in the western United States, and fast-track innovation into a highly respected hospital environment.
Lumeon will work closely with the team at Cedar-Sinai and Techstars to develop a number of care pathways, likely to be focused on pre-surgery preparation, discharge management, and post-acute care, with the aim of improving care team coordination, minimizing variation, and systematically adapting care to the needs of individuals.
The program has an excellent track record of long-term success, with a high percentage of the companies in the previous cohort going to on win contracts with Cedars-Sinai.
The full press release can be found below.
……………………………………………………………………………………………………………………………………………………………………………………
Breakthrough Health-Tech Companies Get Boost to Transform Healthcare
Los Angeles (Sept. 19, 2017) — Cedars-Sinai today launched its third health-tech accelerator class with 10 startups whose innovative technologies aim to transform the delivery and quality of healthcare.
The companies were selected for the Cedars-Sinai Accelerator Powered by Techstars, an intensive, three-month program providing financial backing, training and exposure to a global entrepreneurial network that can speed ideas and solutions to the healthcare marketplace.
The startups will develop and refine their products with mentoring from leading Cedars-Sinai physicians, as well as executives from Cedars-Sinai and Techstars, an organization that works with entrepreneurs to successfully cultivate their ideas. The companies also will receive an initial investment of $120,000 and access to Techstars’ worldwide network of investors, mentors, alumni and corporate partners.
Through their innovations, the companies seek to address some of healthcare’s most pressing challenges, particularly the experience of patients. Tasso, for example, makes blood testing simpler and more affordable through its device that allows patients to collect their own blood samples at the push of a button and send to labs for a broad range of diagnostic tests.
NarrativeDx has developed a patient experience management tool that allows facilities to better understand and respond to feedback and concerns by collecting patients’ comments from focus groups, discharge surveys, social media channels and doctor review sites.
GYANT, an artificial intelligence bot, uses text messaging or voice-enabled technology to connect with patients and ask about symptoms in a chat setting. Based on responses, it helps identify probable causes of particular conditions and provides information and next steps.
Lumeon’s automated care pathways allow providers to set up protocols to ensure that patients get the right follow-up care based on advice they’ve received and procedures they’ve undergone. It allows physicians to provide more effective health outcomes at a lower cost.
(To read a full list of companies selected for the Cedars-Sinai Accelerator Powered by Techstars, visit: www.cedars-sinai.edu/accelerator.)
“The innovations these companies bring to the accelerator have the potential to dramatically improve and streamline the delivery of healthcare,” said Darren Dworkin, chief information officer at Cedars-Sinai. “Through this program, these companies will test and improve their ideas. By working with world-class physicians, they will advance their technologies and push their companies to the next level.”
The companies were selected in a competitive process among hundreds of startups around the globe that applied.
“I’m excited to mentor and work with these pioneering startups,” said Matt Kozlov, managing director of the Cedars-Sinai Accelerator Powered by Techstars. “Techstars helps entrepreneurs succeed and through our partnership with Cedars-Sinai, more than 30 companies have accelerated their growth. It’s exciting to welcome the new startups to our program.”
Past company participants in the accelerator have achieved notable success, including Inscope Medical, which completed FDA registration for its high-tech disposable laryngoscope in April; Stasis Labs, which has successfully deployed a cloud-connected vital signs monitoring system to 12 hospitals across India.; WELL Health, a text messaging platform for patients used by more than 120 physician offices and clinics at Cedars-Sinai; and Deep 6 AI, which uses artificial intelligence to help researchers find patients for clinical trials, and is deploying across Cedars-Sinai.
About Cedars-Sinai
Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars-Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow’s health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.
About Techstars
Techstars helps entrepreneurs succeed. Through the Techstars Worldwide Entrepreneur Network, founders connect with other entrepreneurs, experts, mentors, alumni, investors, community leaders, and corporations to grow their companies. Techstars operates four divisions: Techstars Startup Programs, Techstars Mentorship-Driven Accelerator Programs, Techstars Corporate Innovation Partnerships, and the Techstars Venture Capital Fund. More information at www.techstars.com
About Lumeon
Lumeon enables healthcare organizations to automate systems and processes, bringing together the full potential of their organization to deliver high performance, team-centered healthcare. The industry-leading Lumeon Care Pathway Management (CPM) platform and suite of solutions empower health organizations to take control of their end-to-end care delivery model and maximize the use of resources. By iteratively designing and deploying efficient pathways, organizations reduce cost and minimize variation, while flexibly adapting to emerging needs. With headquarters in the USA and Europe, Lumeon serves some of the largest health enterprises across the globe. Find out more at www.lumeon.com